| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/04/2013 | CN102686720B Method for inducing differentiation of dental pulp cells into odontoblasts |
| 12/04/2013 | CN102660548B Preparation and application of South China sea conus textile conotoxin TxO10 |
| 12/04/2013 | CN102600457B Compound propolis composition used for treating pig viral diarrhea and preparation method thereof |
| 12/04/2013 | CN102585012B Preparation method for grouper alpha interferon derivative and application |
| 12/04/2013 | CN102516358B Angiotensin I transferase inhibitor derived from scale collagen and application thereof |
| 12/04/2013 | CN102477066B N-(S-1,2,3,4-tetrahydro-6,7-dihydroxyisoquinolyl-3-formyl)amino acid, synthetic method thereof, and application thereof |
| 12/04/2013 | CN102399293B Recombinant protein specifically bound with fibrin and application thereof |
| 12/04/2013 | CN101663314B Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 12/04/2013 | CN101378772B Tissue protective peptides and uses thereof |
| 12/04/2013 | CN101143215B Proteinase inhibitor nervous cell protecting function and application |
| 12/03/2013 | US8598324 Anti-pathogen treatments |
| 12/03/2013 | US8598321 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 12/03/2013 | US8598319 Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins |
| 12/03/2013 | US8598318 Modified human thymic stromal lymphopoietin |
| 12/03/2013 | US8598316 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 12/03/2013 | US8598315 Protein transduction domains derived from secretory leukocyte protease inhibitor |
| 12/03/2013 | US8598314 Peptide-peptidase-inhibitor conjugates and methods of making and using same |
| 12/03/2013 | US8598313 Compositions for ameliorating cell proliferative disorders and methods of making and using them |
| 12/03/2013 | US8598312 Inhibitors of antigen presentation by MHC class II molecules |
| 12/03/2013 | US8598311 Complexation of fatty acid-conjugated molecules with albumin |
| 12/03/2013 | US8598215 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 12/03/2013 | US8598146 Methods for identifying modulators of protein kinase C-epsilon (PKCε) and method of treatment of aberrant glucose metabolism associated therewith |
| 12/03/2013 | US8598133 Methods for treating pain |
| 12/03/2013 | US8598127 Peptides for inhibiting MDM2 function |
| 12/03/2013 | US8598126 Peptides for inhibiting the HPV-E6 oncoprotein |
| 12/03/2013 | US8598125 CDCA1 peptide and pharmaceutical agent comprising the same |
| 12/03/2013 | US8598124 Peptides derived from HMG-CoA reductase and cosmetic and/or pharmaceutical composition containing same |
| 12/03/2013 | US8598123 Peptide analogues |
| 12/03/2013 | US8598122 Antagonistic peptides for frizzled-1 and frizzled-2 |
| 12/03/2013 | US8598121 Variants of C-type natriuretic peptide |
| 12/03/2013 | US8598120 Methods for treatment using amylin family peptides |
| 12/03/2013 | US8598119 Methods and compositions for sleep disorders and other disorders |
| 12/03/2013 | US8598118 Hepatocyte growth factor mimics as therapeutic agents |
| 12/03/2013 | US8598116 Treatment of influenza virus infection |
| 12/03/2013 | US8598115 Cyclic compound and salt thereof |
| 12/03/2013 | US8598114 Antimicrobial compounds |
| 12/03/2013 | US8598113 Polypeptides |
| 12/03/2013 | US8598112 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 12/03/2013 | US8598111 Products and methods using soy peptides to lower total and LDL cholesterol levels |
| 12/03/2013 | US8597950 Two-component RNA virus-derived plant expression system |
| 12/03/2013 | US8597906 Glycosylation of molecules |
| 12/03/2013 | US8597902 Peptide protection against ultraviolet light toxicity |
| 12/03/2013 | US8597893 Human phospholipase A2 epsilon |
| 12/03/2013 | US8597660 Therapeutic approach to neurodegenerative disorders using a TFP5-peptide |
| 12/03/2013 | US8597659 Tetrameric cytokines with improved biological activity |
| 12/03/2013 | US8597657 Mutated env sequence involved in the modulation of the immunosuppressive effect of viral proteins |
| 12/03/2013 | US8597656 Process for the production of immunogenic compositions |
| 12/03/2013 | US8597653 Asymmetrically branched polymer conjugates and microarray assays |
| 12/03/2013 | US8597651 Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |
| 12/03/2013 | US8597645 Cancer treatment with endothelin receptor antagonists |
| 12/03/2013 | US8597641 Instant enzyme formulations for animal nutrition |
| 12/03/2013 | US8597640 Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging |
| 12/03/2013 | US8597635 Interferon alpha-2B modified by polyethylene glycol and methods of preparation thereof |
| 12/03/2013 | US8597634 Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof |
| 12/03/2013 | US8597619 Thickener or gellant for oil materials, gel composition comprising same, and method of producing cosmetic material or topical agent |
| 12/03/2013 | US8597604 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production |
| 12/03/2013 | CA2694235C Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
| 12/03/2013 | CA2566481C Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities |
| 12/03/2013 | CA2519227C Nogo receptor binding protein |
| 12/03/2013 | CA2504270C Peptide fragments of the harp factor inhibiting angiogenesis |
| 12/03/2013 | CA2499837C Human papillomavirus polypeptides and immunogenic compositions |
| 12/03/2013 | CA2474497C Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 12/03/2013 | CA2449426C Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 12/03/2013 | CA2397207C Novel stra6 polypeptides |
| 12/03/2013 | CA2304956C Pharmaceutical composition for preventing or treating ischemic diseases |
| 12/03/2013 | CA2304796C Hepatitis c receptor protein cd81 |
| 12/03/2013 | CA2240834C Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 12/03/2013 | CA2213610C Ingap protein involved in pancreatic islet neogenesis |
| 11/28/2013 | WO2013177593A2 Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies |
| 11/28/2013 | WO2013177588A1 C1q/TNF-RELATED PROTEIN-9 (CTRP9) AND USE IN PREVENTION AND TREATMENT OF METABOLIC DISORDERS |
| 11/28/2013 | WO2013177584A2 FVIIa VARIANTS EXHIBITING ALTERED INTERACTION WITH ENDOTHELIAL PROTEIN C RECEPTOR (EPCR) AND METHODS OF USE THEREOF FOR MODULATING HEMOSTASIS |
| 11/28/2013 | WO2013177570A1 Methods of preventing or treating disease of the central nervous system using rlip76 |
| 11/28/2013 | WO2013177565A1 Insulin-pramlintide compositions and methods for making and using them |
| 11/28/2013 | WO2013177529A1 Relaxin-like compounds and uses thereof |
| 11/28/2013 | WO2013177432A1 Methods of treating obesity |
| 11/28/2013 | WO2013177428A1 Methods for increasing muscle contractility |
| 11/28/2013 | WO2013177231A1 Translocation of non-natural chemical entities through anthrax protective antigen pore |
| 11/28/2013 | WO2013177198A1 Ledgf peptides and formulations thereof for treatment of degenerative disorders |
| 11/28/2013 | WO2013177197A1 Dendrimer conjugates for coating cells |
| 11/28/2013 | WO2013177187A2 Synergistic tumor treatment with extended-pk il-2 and therapeutic agents |
| 11/28/2013 | WO2013177063A1 Uses of protein precursors as prodrugs |
| 11/28/2013 | WO2013177005A1 Metabolic syndrome and chronic disease treatments |
| 11/28/2013 | WO2013176785A1 Trefoil family factor and uses thereof |
| 11/28/2013 | WO2013176667A2 Maspin-based treatment and prevention of cancer |
| 11/28/2013 | WO2013176623A1 Inhibitors for the treatment of cancer |
| 11/28/2013 | WO2013176563A1 Biologically active peptide complexes |
| 11/28/2013 | WO2013176560A1 An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes |
| 11/28/2013 | WO2013176504A1 Novel protein and use thereof |
| 11/28/2013 | WO2013176054A1 Agent containing ascorbic acid derivative, and use for said agent |
| 11/28/2013 | WO2013175805A1 Ghrelin receptor agonists for the treatment of achlorhydria |
| 11/28/2013 | WO2013175504A2 Herbal composition for vaginal treatment |
| 11/28/2013 | WO2013175469A1 Compositions and methods for the treatment and diagnosis of neurodegenerative disorders |
| 11/28/2013 | WO2013175399A1 Laccase of podospora anserina and uses of same |
| 11/28/2013 | WO2013175172A1 Therapeutic for treating clostridium difficile infection |
| 11/28/2013 | WO2013175007A1 Agents for treating cystic fibrosis |
| 11/28/2013 | WO2013174978A1 Somatostatin receptor agonist formulations |
| 11/28/2013 | WO2013174920A1 Complement component c5a- based vaccine |
| 11/28/2013 | WO2013173941A1 Peptide and the use thereof |
| 11/28/2013 | WO2013173923A1 Formulations of human tissue kallikrein-1 for parenteral delivery and related methods |
| 11/28/2013 | WO2012125828A8 Methods of treating breast cancer with anthracycline therapy |